Nanosphere Financial Statements
Nanosphere Financial Information
| Company Type | Public Single Location |
|---|---|
| Fiscal Year-End | December |
Nanosphere Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 1.2 | 1.1 | 1.9 |
| Gross Profit ($ mil.) | 1.1 | 1.1 | 1.8 |
| Operating Income ($ mil.) | (33.7) | (21.8) | (16.0) |
| Total Net Income ($ mil.) | (53.1) | (23.5) | (15.9) |
| Diluted EPS (Net Income) | (14.16) | (52.78) | (30.80) |
Nanosphere Stock Quote & Chart
| 10/07/08 15:00:07 EST •
NASDAQ •
6.60
•
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Nanosphere Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 169.47 | 2.00 | 1.38 |
| Price/Earnings Ratio | -- | 20.40 | 14.44 |
| Price/Book Ratio | 1.76 | 1.99 | 1.34 |
| Price/Cash Flow Ratio | -- | 14.40 | 8.71 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Nanosphere Financial Ratios
Nanosphere Competitive Intelligence
| Abbott Labs | Applied Biosystems Inc. | Siemens Healthcare Diagnostics | |
|---|---|---|---|
| Annual Sales ($ mil.) | 25,914.2 | 2,361.5 | 198.7 |
| Employees | 68,000 | -- | 2,406 |
| Market Cap ($ mil.) | 88,253.6 | 7,327.9 | -- |
Competitive Landscape





